
Sales value of subsidized pharmaceuticals in Sweden 2008-2022
The sales value of subsidized pharmaceuticals in Sweden decreased from 2011 down to a minimum point of around 18.9 billion Swedish kronor in 2013. The following years, the sales value of subsidized pharmaceuticals increased steadily each year, and reached the highest value of around 24.7 billion Swedish kronor in 2018.